Director, Global Medical Affairs - Rare Metabolic Disorders - Remote

1w1 week ago

Travere Therapeutics

San Diego, US · Full-time · $189,000 – $268,000

About this role

Be a part of a global team inspired to make a difference in the lives of people living with rare disease. The Director, Global Medical Affairs – Rare Metabolic Disorders serves as a strategic scientific leader supporting a Phase 3 asset in the genetic metabolic disease space. This role shapes and executes global medical strategy in preparation for potential regulatory approval and launch.

Act as a subject matter expert in inborn errors of metabolism, leading evidence generation planning, scientific narrative development, and external engagement with professional societies. Translate Phase 3 data into a compelling and differentiated scientific story through close collaboration with Clinical Development. Work cross-functionally with Commercial, Market Access, Medical Training, Scientific Communication, and Field Medical teams.

Thrive in a collaborative, diverse, fast-paced environment while sharing the mission to identify, develop, and deliver life-changing therapies to rare patients. Stick by values centered on patients, courage, community, and collaboration. Establish strong external partnerships that advance disease understanding and patient care.

Pursue the vision of becoming a leading biopharmaceutical company dedicated to innovation and hope in the global rare disease community. Forge new paths elevating science and service for rare patients. Experience rewarding work both professionally and personally by making a difference.

Requirements

Subject matter expertise in inborn errors of metabolism
Strong foundation in rare metabolic disorders
Experience shaping global medical strategy for Phase 3 assets in genetic metabolic diseases
Proven ability to lead evidence generation planning and data interpretation
Track record in scientific narrative development and external stakeholder engagement
Cross-functional collaboration with Clinical Development, Commercial, and Market Access teams
Knowledge of professional societies, guideline bodies, and key opinion leaders in rare diseases
Strategic experience in pre-launch medical affairs for rare disease therapies

Responsibilities

Support overall Medical strategy for rare metabolic conditions
Translate Phase 1/2 and Phase 3 data into clear scientific insights and positioning
Provide strategic input across initiatives, ensuring scientific rigor and clinical relevance
Serve as the internal medical expert in rare metabolic disorders with strong foundation in inborn errors of metabolism
Lead integrated evidence generation planning aligned with Phase 3 and pre-launch needs
Identify and prioritize evidence gaps critical for regulatory, payer, and clinical adoption
Develop and execute a strategic engagement plan with US professional societies and scientific organizations
Represent the company at advisory boards, congresses, and scientific forums